Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Medtronic
US Army
McKesson
AstraZeneca
Novartis
Deloitte
QuintilesIMS
Fish and Richardson
Boehringer Ingelheim

Generated: January 22, 2018

DrugPatentWatch Database Preview

MECAMYLAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Mecamylamine Hydrochloride patents expire, and when can generic versions of Mecamylamine Hydrochloride launch?

Mecamylamine Hydrochloride is a drug marketed by Nexgen Pharma and is included in one NDA.

The generic ingredient in MECAMYLAMINE HYDROCHLORIDE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.
Drug patent expirations by year for MECAMYLAMINE HYDROCHLORIDE
Pharmacology for MECAMYLAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MECAMYLAMINE HYDROCHLORIDE

US Patents and Regulatory Information for MECAMYLAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054-001 Mar 19, 2013 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Mallinckrodt
Julphar
Chubb
Medtronic
Chinese Patent Office
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot